Osteoporosis
Conditions
Interventions
Osteoporosis (Zoledronic acid):None
Osteoporosis (Denosumab):None
Sponsors
Affiliated Kunshan Hospital of Jiangsu University
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age 50 or older. 2.diagnosed with osteoporosis. 3.patients receiving anti-osteoporosis medication treatment (zoledronic acid and denosumab) at a hospital. 4. Have identity information for matching and follow-up.
Exclusion criteria
Exclusion criteria: 1. Changed treatment plans during follow-up due to various reasons after using zoledronic acid or denosumab (e.g., using zoledronic acid first and denosumab second). 2. The patient was recorded only once for using either zoledronic acid or denosumab, and subsequent visit information could not be registered by the region. 3. The patient has a history of tumors or related vascular diseases. 4. Previous history of atrial fibrillation and stroke 5. Patients with malignant tumors 6. Renal insufficiency 7. Autoimmune diseases 8. Previous diagnosis of atrial fibrillation (or stroke) 9. Taking anti-arrhythmic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Zoledronic acid injection;Denosumab injection; | — |
Countries
China
Contacts
Public ContactLu ke
Department of Orthopedics, Affiliated Kunshan Hospital of Jiangsu University
Outcome results
None listed